Wegovy Cost in 2026: With & Without Insurance

Wegovy List Price Breakdown

Wegovy is Novo Nordisk's semaglutide approved for weight loss. Ozempic is the same medicine, approved for type 2 diabetes, so insurers are more likely to cover Wegovy when weight is the goal.

The list price (the maker's price before discounts, also called the wholesale acquisition cost) is $1,349 a month at every dose. Pharmacy cash prices can run higher.

Novo Nordisk announced on February 24, 2026 that Wegovy's list price falls to $675 a month at every dose on January 1, 2027, about 50% lower (Novo Nordisk). Self-pay prices are not affected.

Because every dose costs the same, the low starting doses cost as much as the higher ones.

Self-Pay: The Novo Nordisk Savings Offer

Without insurance coverage, Wegovy pens cost $349 per month at every dose through NovoCare Pharmacy and participating telehealth providers. New patients pay $199 per month for their first two monthly fills, through December 31, 2026 (NovoCare, read October 22, 2026).

Key details of this offer:

• Standing price: $349/month for 0.25, 0.5, 1, 1.7 or 2.4 mg; $399/month for Wegovy HD 7.2 mg
• New-patient price: $199/month for the first 2 fills of 0.25 mg or 0.5 mg
• Duration: Introductory offer extended through December 31, 2026 (first 2 monthly fills of 0.25 mg or 0.5 mg); $349/month standing self-pay after that
• Eligibility: Patients without insurance coverage for Wegovy, or those whose insurance denies the claim
• How to access: Through NovoCare.com or participating telehealth providers
• Government coverage: NovoCare says patients enrolled in government, state, or federally-funded programs are able to pay the self-pay price. The offer operates outside of insurance, so it does not count toward a deductible and cannot be submitted for reimbursement. The savings card, which is different, excludes government beneficiaries

For comparison, Eli Lilly's LillyDirect sells Zepbound from $299/month at the 2.5 mg starting dose; see the Zepbound cost guide.

Wegovy Pill Prices by Dose

The Wegovy pill launched in January 2026. It is the first FDA-approved semaglutide for weight loss that you take by mouth instead of as a shot.

Pricing for Oral Wegovy:

• 1.5 mg: $149/month self-pay
• 4 mg: $199/month self-pay
• 9 mg and 25 mg: $299/month self-pay
• With commercial insurance that covers it: as little as $25/month with the Wegovy Savings Offer (savings capped at $100/month)

The pill is taken once a day. In its main trial (OASIS 4), adults on the highest dose lost 13.6% of their body weight on average over 64 weeks. In the shot's main trial (STEP 1), it was 14.9% over 68 weeks.

At $149 a month, the lowest-strength pill is the cheapest self-pay price for FDA-approved semaglutide. Most people move to higher strengths, which cost $299 a month.

Wegovy with Insurance

More plans cover Wegovy than at its 2021 launch, but coverage still varies a lot. Here is what to expect:

• With the Wegovy Savings Offer: as little as $25/month if your commercial plan covers Wegovy; savings are capped at $100/month, so a higher copay leaves the difference to you
• Government plans: Medicare, Medicaid and other government beneficiaries cannot use the savings offer
• Approval first: most plans need your doctor to ask for approval (prior authorization) and show your BMI is 30 or more, or 27 or more with a weight-related health problem
• Other treatments first: some plans want you to try cheaper weight-loss medicines first (step therapy)

Coverage depends on your employer and plan, so check your plan's drug list or call the number on your card. If your plan says no, your prescriber can appeal. Without coverage, the self-pay prices above apply. For how the $25 card works, see our Wegovy coupon guide.

Medicare GLP-1 Bridge

Since July 1, 2026, the Medicare GLP-1 Bridge has covered Wegovy, Zepbound and Foundayo at a $50 monthly copay. It is for people with Medicare drug coverage (Part D) who meet the rules set by CMS. Key points:

• Copay: $50/month for eligible beneficiaries
• Eligibility: BMI and clinical criteria defined by CMS; check the CMS Bridge page
• Prior authorization: Required; must be submitted by treating physician
• Covered medications: Wegovy (injection and pill), Zepbound, Foundayo
• Not covered: Ozempic prescribed off-label for weight loss

Medicare Part D had excluded weight-loss drugs since the program began; the Bridge runs through December 31, 2027.

For a complete breakdown, see our Medicare GLP-1 Coverage Guide.

Compounded Semaglutide Alternative

Compounded semaglutide uses semaglutide as its active ingredient and is not FDA-approved, prepared by a licensed pharmacy for an individual prescription. Tracked telehealth providers list it from $79 to $299 a month in medication price. The lowest rates usually need a 6- or 12-month plan, and labs, consultation or dose charges may be extra.

It is not FDA-approved. The FDA said the semaglutide shortage ended on February 21, 2025. Its grace periods for compounding pharmacies ended on April 22 and May 22, 2025 (FDA). Pharmacies now make it only for an individual patient's prescription. Compare every brand and compounded price on our semaglutide cost page, or read our compounded vs brand comparison.

NovoCare and Manufacturer Coupons

Novo Nordisk offers several programs to reduce the cost of Wegovy: